Pharmaceutical News

Sun Pharmaceutical Industries Ltd. announced that along with Caraco Pharmaceutical Laboratories, Ltd , it had entered into agreements with Forest Laboratories, Inc., Forest Laboratories Holdings, Ltd., and H. Lundbeck A/S to settle the legal proceedings related to Lexapro tablets.

Teva Pharmaceutical Industries Ltd. announced today that it will release its second quarter 2009 financial results on Tuesday, July 28, 2009.

Main Category: Smoking / Quit Smoking Also Included In: Regulatory Affairs / Drug Approvals ; Pharma Industry / Biotech Industry Article Date: 09 Jul 2009 - 2:00 PDT Watson Pharmaceuticals, Inc.

In Newport, RI, August 7 - 9, 2009 and CAREFUSION NEW YORK JAZZ FESTIVAL in New York City, June 2010 Are New Names for Jazz Festivals at Historic Sites NEW YORK, NY, David Schlotterbeck, CEO of CareFusion, announced today that the corporation will be the title sponsor for George Wein's Jazz Festival 55 in Newport, RI.

A West Side medical manufacturing plant's operations and employment are not expected to be affected by owner Cardinal Health's planned spinoff of its medical technology products divisions into a new, public company, CareFusion Corp., a Cardinal spokesman said.

Main Category: Prostate / Prostate Cancer Also Included In: Regulatory Affairs / Drug Approvals ; Pharma Industry / Biotech Industry Article Date: 08 Jul 2009 - 2:00 PDT Mylan Inc.

Closing arguments have ended in the state of Alabama 's lawsuit against a California -based drug maker accused of cheating the state's Medicaid program out of millions of dollars.

The first American Journal of Nursing Conference: Advancing Excellence in Nursing Practice will bring together a multidisciplinary group of nurses dedicated to improving the health and quality of life for patients on October 4-6, at the Hyatt Regency McCormick Place in Chicago, IL.

Pharmasset, Inc. announced today the nomination of PSI-352938 as a lead development candidate from two series of purine analogs for the treatment of chronic hepatitis C virus infection.

A new sponsor has emerged to resurrect New York's flagship jazz festival and help support some of the country's largest and oldest jazz events, organizers said Tuesday.

Almost everyone agrees that the opportunities for nanotechnology in pharmaceutical manufacturing and development are vast and that nanotechnology as a platform for new technology development is potentially larger than the plastics industry of the mid-20th century.

Dublin - Research and Markets has announced the addition of the "Comparison of Pharma Outsourcing between China and India" report to their offering.

Caraco Pharmaceutical Laboratories, Ltd., announced that it is in the process of instituting an indefinite reduction in its workforce of approximately 350 employees in order to align its expenses with the current voluntary cessation of its manufacturing operations in connection with the recent action by the United States Food and Drug ...

Two companies recently announced that their experimental hepatitis C therapies had moved further along in clinical trials.

Main Category: Fertility Also Included In: Regulatory Affairs / Drug Approvals ; Pharma Industry / Biotech Industry Article Date: 04 Jul 2009 - 2:00 PDT Watson Pharmaceuticals, Inc.

He has also written a book critical of the pharmaceutical industry , and writes a blog that is also skeptical about certain aspects of current psychiatric dogma.

The rate of methicillin-resistant Staphylococcus aureus infections in U.S. neonatal intensive care units has more than tripled in recent years, reports a study in the July issue of The Pediatric Infectious Disease Journal .

Teva Pharmaceutical Industries Ltd., the Jerusalem drugmaker, said on Wednesday that the U.S. Food and Drug Administration cleared the company to market a generic version of Ortho McNeil Janssen's Ortho Tri-Cyclen Lo oral contraceptive.

June 30, 2009 U.S. Marshals, at the request of the Food and Drug Administration, recently seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd.

Teva Pharmaceutical Industries Ltd. and Antares Pharma Inc. said Monday that the Food and Drug Administration has approved the use of Antares' needle-free injection device to administer Teva's Tev-Tropin human growth hormone.